<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000470256"><TermName>humanized monoclonal antibody</TermName><TermPronunciation>(HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee)</TermPronunciation><TermDefinition><DefinitionText>A type of antibody made in the laboratory by combining a human antibody with a small part of a mouse or rat monoclonal antibody. The mouse or rat part of the antibody binds to the target antigen, and the human part makes it less likely to be destroyed by the body's immune system.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716745" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;humanized monoclonal antibody&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716744" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anticuerpo monoclonal humanizado&quot;" language="es" id="_4"/><SpanishTermName>anticuerpo monoclonal humanizado</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de anticuerpo producido en el laboratorio mediante la combinación de un anticuerpo humano con una pequeña porción de un anticuerpo monoclonal de un ratón o una rata. La porción del anticuerpo de la rata o el ratón se une al antígeno objetivo, y la parte humana hace menos probable que el sistema inmunitario del cuerpo lo destruya.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-04</DateFirstPublished></GlossaryTerm>
